Screener
Enliven Therapeutics ELVN Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Enliven Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211982
FAQ
- What is Enliven Therapeutics's debt-to-equity?
- Enliven Therapeutics (ELVN) reported debt-to-equity of 0× in Q1 2026.
- How has Enliven Therapeutics's debt-to-equity changed year-over-year?
- Enliven Therapeutics's debt-to-equity decreased by 70.8% year-over-year, from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Enliven Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude